Solving Complex Chemistry Challenges
Some molecules require more than standard execution. They involve unstable intermediates, hazardous conditions and tightly controlled impurity profiles.
Our approach integrates molecular design, process development and manufacturing within a single platform. What is defined at the lab stage is carried forward into scale-up, ensuring continuity of knowledge, reduced technical risk and predictable performance at commercial scale.
Our CDMO Platform
Built to support complex and hazardous chemistry at scale.
0
manufacturing plants
0
dedicated hydrogenation block
0
total reactor capacity
High-pressure capability up to
0
Core Capabilities
Complex and Hazardous Chemistry
Execution across high-pressure, cryogenic and multi-step reaction systems, including handling of reactive reagents and sensitive chemistries.
Integrated Development to Commercial Supply
A single pathway from route design through pilot to cGMP manufacturing. No disruption between stages.
High-Containment, High-Safety Execution
Controlled environments and disciplined operating systems designed for hazardous reactions.
GMP & Regulatory Rigour
Audit-ready systems aligned to global standards, supporting consistent and compliant execution.
Designed for Innovator Programs
We engage early to define scalable routes, stabilise processes and establish impurity control strategies.
Development knowledge is retained through pilot and manufacturing stages, ensuring reproducibility and reducing scale-up uncertainty.
From Development to Commercial Supply
A continuous system where process understanding is retained, reducing rework and enabling predictable scale-up.
Route design
Process development
Pilot validation
cGMP manufacturing
Commercial supply
Manufacturing Infrastructure
Our Dewas site is designed to handle complex and hazardous chemistry at scale.
Unit 1
Flexible manufacturing for early-stage and mid-scale production.
Unit 2
Expanded batch capability with larger reactor volumes and integrated downstream systems.
Unit 3
Advanced manufacturing for high-pressure and complex reaction systems.
Dedicated Hydrogenation Block
Specialised infrastructure for controlled high-pressure hydrogenation.
Unit 4
New cGMP facility adding ~200 m³ reactor capacity, supporting future demand.
—
Built Around Your Expectations
We operate as a focused CDMO partner.
- Confidentiality and IP protection are foundational
- Responsive execution aligned to development timelines
- Safety-led operations for hazardous chemistry
- Regulatory compliance and audit readiness at every stage
If your molecule requires careful design and reliable scale-up, our team can support its progression.
↑